4-119319026-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000134.4(FABP2):c.*15G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0337 in 1,585,764 control chromosomes in the GnomAD database, including 1,113 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.041   (  193   hom.,  cov: 32) 
 Exomes 𝑓:  0.033   (  920   hom.  ) 
Consequence
 FABP2
NM_000134.4 3_prime_UTR
NM_000134.4 3_prime_UTR
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.286  
Publications
9 publications found 
Genes affected
 FABP2  (HGNC:3556):  (fatty acid binding protein 2) The protein encoded by this gene is an intracellular fatty acid-binding protein that participates in the uptake, intracellular metabolism, and transport of long-chain fatty acids. The encoded protein is also involved in the modulation of cell growth and proliferation. This protein binds saturated long-chain fatty acids with high affinity, and may act as a lipid sensor to maintain energy homeostasis. [provided by RefSeq, Aug 2017] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85). 
BP6
Variant 4-119319026-C-T is Benign according to our data. Variant chr4-119319026-C-T is described in ClinVar as Benign. ClinVar VariationId is 1226479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0621  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0414  AC: 6292AN: 151858Hom.:  191  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6292
AN: 
151858
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0325  AC: 7602AN: 234116 AF XY:  0.0330   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
7602
AN: 
234116
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0329  AC: 47174AN: 1433788Hom.:  920  Cov.: 28 AF XY:  0.0330  AC XY: 23580AN XY: 714010 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
47174
AN: 
1433788
Hom.: 
Cov.: 
28
 AF XY: 
AC XY: 
23580
AN XY: 
714010
show subpopulations 
African (AFR) 
 AF: 
AC: 
1849
AN: 
31654
American (AMR) 
 AF: 
AC: 
864
AN: 
40736
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
432
AN: 
25770
East Asian (EAS) 
 AF: 
AC: 
557
AN: 
37788
South Asian (SAS) 
 AF: 
AC: 
3099
AN: 
83324
European-Finnish (FIN) 
 AF: 
AC: 
2062
AN: 
53128
Middle Eastern (MID) 
 AF: 
AC: 
587
AN: 
5658
European-Non Finnish (NFE) 
 AF: 
AC: 
35659
AN: 
1096554
Other (OTH) 
 AF: 
AC: 
2065
AN: 
59176
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.419 
Heterozygous variant carriers
 0 
 1875 
 3750 
 5626 
 7501 
 9376 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 1296 
 2592 
 3888 
 5184 
 6480 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0415  AC: 6301AN: 151976Hom.:  193  Cov.: 32 AF XY:  0.0418  AC XY: 3106AN XY: 74292 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6301
AN: 
151976
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
3106
AN XY: 
74292
show subpopulations 
African (AFR) 
 AF: 
AC: 
2662
AN: 
41498
American (AMR) 
 AF: 
AC: 
517
AN: 
15246
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
55
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
30
AN: 
5176
South Asian (SAS) 
 AF: 
AC: 
155
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
393
AN: 
10548
Middle Eastern (MID) 
 AF: 
AC: 
27
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
2309
AN: 
67918
Other (OTH) 
 AF: 
AC: 
94
AN: 
2104
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.508 
Heterozygous variant carriers
 0 
 317 
 635 
 952 
 1270 
 1587 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 78 
 156 
 234 
 312 
 390 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
124
AN: 
3458
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.